We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+2.64%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
-$20.8M
Cap. Flow
-$39.5M
Cap. Flow %
-2.66%
Top 10 Hldgs %
46.58%
Holding
135
New
2
Increased
16
Reduced
37
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$5.09M
2
MSFT icon
Microsoft
MSFT
+$4.03M
3
V icon
Visa
V
+$2.27M
4
NVO
Novo Nordisk
NVO
+$1.24M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$981K

Top Sells

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$15.7M
2
META icon
Meta Platforms (Facebook)
META
+$6.33M
3
INTC icon
Intel
INTC
+$5.53M
4
EBAY icon
eBay
EBAY
+$4.55M
5
SNPS icon
Synopsys
SNPS
+$2.68M

Sector Composition

Rank Sector Weight
1 Technology 44.99%
2 Communication Services 15.72%
3 Healthcare 14.39%
4 Consumer Discretionary 11.2%
5 Financials 10.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRUS icon
51
Cirrus Logic
CRUS
$6.87B
$3.97M 0.27%
31,978
-2,198
-6% -$291K
KLIC icon
52
Kulicke & Soffa
KLIC
$4.76B
$3.94M 0.27%
87,414
– –
COR icon
53
Cencora
COR
$62.2B
$3.1M 0.21%
13,753
– –
FFIV icon
54
F5
FFIV
$22.8B
$3.07M 0.21%
13,961
– –
CAH icon
55
Cardinal Health
CAH
$54.5B
$3.04M 0.2%
27,493
– –
PSN icon
56
Parsons
PSN
$6.64B
$2.98M 0.2%
28,790
– –
AEIS icon
57
Advanced Energy
AEIS
$10.9B
$2.98M 0.2%
28,328
– –
ENSG icon
58
The Ensign Group
ENSG
$10.7B
$2.87M 0.19%
19,981
– –
DGX icon
59
Quest Diagnostics
DGX
$26B
$2.8M 0.19%
18,025
– –
UTHR icon
60
United Therapeutics
UTHR
$26.1B
$2.69M 0.18%
7,515
-1,500
-17% -$507K
NDSN icon
61
Nordson
NDSN
$16.9B
$2.59M 0.17%
9,854
– –
TMO icon
62
Thermo Fisher Scientific
TMO
$214B
$2.56M 0.17%
4,137
– –
SAIC icon
63
Saic
SAIC
$5.14B
$2.53M 0.17%
18,166
– –
ELV icon
64
Elevance Health
ELV
$83.7B
$2.51M 0.17%
4,833
– –
EXEL icon
65
Exelixis
EXEL
$14.2B
$2.5M 0.17%
96,517
-25,000
-21% -$621K
JAZZ icon
66
Jazz Pharmaceuticals
JAZZ
$16.1B
$2.48M 0.17%
22,295
+8,950
+67% +$981K
MELI icon
67
Mercado Libre
MELI
$94.4B
$2.46M 0.17%
1,200
– –
UNH icon
68
UnitedHealth
UNH
$389B
$2.44M 0.16%
4,169
– –
LRCX icon
69
Lam Research
LRCX
$337B
$2.42M 0.16%
29,700
– –
RVTY icon
70
Revvity
RVTY
$12.4B
$2.24M 0.15%
17,551
– –
VRTX icon
71
Vertex Pharmaceuticals
VRTX
$124B
$2.21M 0.15%
4,759
– –
YOU icon
72
Clear Secure
YOU
$5.43B
$2.2M 0.15%
66,448
– –
DHR icon
73
Danaher
DHR
$140B
$2.2M 0.15%
7,920
– –
DIOD icon
74
Diodes
DIOD
$3.69B
$2.16M 0.15%
33,754
-21,003
-38% -$1.45M
CRWD icon
75
CrowdStrike
CRWD
$185B
$2.15M 0.14%
30,704
– –
1 2
3
4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q3 2024 Portfolio in Review

As of Q3 2024, Oak Associates held 135 positions worth $1.49B, down 1.4% from $1.51B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Oak Associates's Q3 2024 filing shows 2 new, 16 increased, 37 reduced and 6 closed positions. Its largest new stake was Novo Nordisk: 9,283 shares worth $1.11M. The largest sale was KLA, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 46% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q3 2024 buy was Novo Nordisk: 9,283 shares worth $1.11M.
  • Oak Associates added most to Pfizer in Q3 2024, an estimated $5.09M increase.
  • Oak Associates's biggest Q3 2024 reduction was KLA, cutting an estimated $15.7M.
  • Oak Associates fully exited Intel in Q3 2024, selling an estimated $5.53M.
  • Oak Associates's ten largest holdings make up 47% of its $1.49B portfolio in Q3 2024.
  • Oak Associates opened 2 new positions and closed 6 in Q3 2024.
  • Oak Associates's portfolio value fell 1.4% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q3 2024, filed 12 Nov 2024.